• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[食管癌高危人群筛查的效果:四川省105561例受检者的筛查结果]

[Efficacy of esophageal cancer screening in high risk population: results of 105 561 subjects in Sichuan province].

作者信息

Wang X, Li B, Bao Y, Wang Y, Wang A R, Qiao L

机构信息

Cancer Prevention and Control Office, Sichuan Cancer Hospital & Sichuan Cancer Center, Chengdu 610041, China.

Department of Endoscopy, Sichuan Cancer Hospital & Sichuan Cancer Ccenter, Chengdu 610041, China.

出版信息

Zhonghua Zhong Liu Za Zhi. 2017 Jan 23;39(1):67-71. doi: 10.3760/cma.j.issn.0253-3766.2017.01.013.

DOI:10.3760/cma.j.issn.0253-3766.2017.01.013
PMID:28104037
Abstract

To analyze the efficacy of endoscopic screening for esophageal cancer in high risk population from high risk areas in order to provide scientific basis for evaluation of the results of early diagnosis and treatment of esophageal cancer. Ten high incidence cities and counties of esophageal cancer in Sichuan province were included in this study. Subjects aged 40-69 years were selected to participate in the endoscopic screening based on the cluster sampling, and the screening-positive subjects were further confirmed by pathological examination. A total of 105 561 subjects were screened during 2006-2014 in 10 cities and counties in Sichuan Province. The detection rate of precancerous lesions was 5.53% (5 841/105 561), and the positive detection rate was 1.13% (1 193/105 561). The overall detection rates of low-grade hyperplasia, moderate hyperplasia, high-grade hyperplasia/carcinoma in situ, early esophageal cancer and invasive carcinoma were 3.87% (4 089/105 561), 1.66% (1 752/105 561), 0.77% (816/105 561), 0.08% (84/105 561) and 0.28% (293/105 561), respectively. The detection rates of all lesions in males were significantly higher than those in females (<0.05), and were gradually increased with age (<0.05). At these ten cities and counties in Sichuan Province with high incidence of esophageal cancer, the endoscopic screening has good effect. There are considerable numbers of patients aged 40-69 with precancerous lesions from the high risk areas. Improving the follow-up work of the population with precancerous lesions will achieve better results of early diagnosis and early treatment.

摘要

分析食管癌高发区高危人群内镜筛查的效果,为评估食管癌早期诊断与治疗效果提供科学依据。本研究纳入四川省食管癌高发的10个市、县。采用整群抽样的方法选取年龄在40 - 69岁的受试者参与内镜筛查,筛查阳性者进一步行病理检查确诊。2006 - 2014年期间,四川省10个市、县共筛查105 561例受试者。癌前病变检出率为5.53%(5 841/105 561),阳性检出率为1.13%(1 193/105 561)。低级别上皮内瘤变、中级别上皮内瘤变、高级别上皮内瘤变/原位癌、早期食管癌及浸润癌的总体检出率分别为3.87%(4 089/105 561)、1.66%(1 752/105 561)、0.77%(816/105 561)、0.08%(84/105 561)和0.28%(293/105 561)。所有病变的男性检出率均显著高于女性(P<0.05),且随年龄增长逐渐升高(P<0.05)。在四川省食管癌高发的这10个市、县,内镜筛查效果良好。有相当数量来自高危地区的40 - 69岁人群存在癌前病变。加强对癌前病变人群的随访工作,将取得更好的早期诊断和早期治疗效果。

相似文献

1
[Efficacy of esophageal cancer screening in high risk population: results of 105 561 subjects in Sichuan province].[食管癌高危人群筛查的效果:四川省105561例受检者的筛查结果]
Zhonghua Zhong Liu Za Zhi. 2017 Jan 23;39(1):67-71. doi: 10.3760/cma.j.issn.0253-3766.2017.01.013.
2
Cytological screening and 15 years' follow-up (1986-2001) for early esophageal squamous cell carcinoma and precancerous lesions in a high-risk population in Anyang County, Henan Province, Northern China.中国北方河南省安阳县高危人群早期食管鳞状细胞癌及癌前病变的细胞学筛查与15年随访(1986 - 2001年)
Cancer Detect Prev. 2005;29(4):317-22. doi: 10.1016/j.cdp.2005.06.004.
3
Epidemiology of esophageal cancer in Yanting - regional report of a national screening programme in China.盐亭食管癌流行病学——中国一项全国性筛查项目的区域报告
Asian Pac J Cancer Prev. 2013;14(4):2429-32. doi: 10.7314/apjcp.2013.14.4.2429.
4
[Results of the endoscopic screening program of esophageal and gastric cardia cancers using iodine staining in Feicheng, Shandong Province, from 2006 to 2012].[2006年至2012年山东省肥城市采用碘染色法进行食管癌和贲门癌内镜筛查项目的结果]
Zhonghua Zhong Liu Za Zhi. 2015 Jul;37(7):549-53.
5
[Multivariate ordinal logistic regression analysis on the association between consumption of fried food and both esophageal cancer and precancerous lesions].[油炸食品消费与食管癌及癌前病变之间关联的多变量有序逻辑回归分析]
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Dec 10;38(12):1616-1619. doi: 10.3760/cma.j.issn.0254-6450.2017.12.006.
6
[Distribution of esophageal squamous cell cancer and precursor lesions in high-risk areas, Linzhou in Henan province and Feicheng in Shandong province of China, 2005-2009].[2005 - 2009年中国河南省林州市和山东省肥城市高危地区食管鳞状细胞癌及癌前病变的分布情况]
Zhonghua Yu Fang Yi Xue Za Zhi. 2015 Aug;49(8):677-82.
7
Esophageal/gastric cancer screening in high-risk populations in Henan Province, China.中国河南省高危人群的食管癌/胃癌筛查
Asian Pac J Cancer Prev. 2014;15(3):1419-22. doi: 10.7314/apjcp.2014.15.3.1419.
8
[Efficacy of esophageal cancer screening program on population at high risk: a survey carried out in people aged 40-69 years in Yangzhong, Jiangsu province].[食管癌筛查项目对高危人群的效果:在江苏省扬中市40 - 69岁人群中开展的一项调查]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Jun 10;41(6):908-912. doi: 10.3760/cma.j.cn112338-20190606-00407.
9
[Results of a screening program on high incidence area of esophageal cancer in Yanting Sichuan from 2006 to 2011].[2006年至2011年四川盐亭食管癌高发区筛查项目结果]
Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Aug;33(8):784-7.
10
[Analysis of results of endoscopic screening of esophageal, gastric cardia and gastric cancers in high risk population].[高危人群食管癌、贲门癌和胃癌内镜筛查结果分析]
Zhonghua Zhong Liu Za Zhi. 2014 Feb;36(2):158-60.

引用本文的文献

1
Profiles and Findings of Population-Based Esophageal Cancer Screening With Endoscopy in China: Systematic Review and Meta-analysis.基于人群的中国内镜食管癌筛查的特征和结果:系统评价和荟萃分析。
JMIR Public Health Surveill. 2023 Jun 1;9:e45360. doi: 10.2196/45360.
2
Detection of Incidental Esophageal Cancers on Chest CT by Deep Learning.深度学习在胸部CT上偶然发现食管癌的检测
Front Oncol. 2021 Sep 16;11:700210. doi: 10.3389/fonc.2021.700210. eCollection 2021.